MATA NATHAN L. enters BELITE BIO, INC with 33.33K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001193125-26-113656
Officer· Chief Scientific Officer
Since Mar 2026
33.33K
Baseline shares
100% direct
33.33K
Direct ownership
2 positions
323.07K
Derivative underlying
3 instruments
2
Security positions
All direct
Non-Derivative Holdings2
American depositary share
DirectShares owned16.67K
Ordinary Share
DirectShares owned16.67K
Total
33.33K direct33.33K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American depositary share | 16.67K | Direct |
| Ordinary Share | 16.67K | Direct |
| Total | 33.33K | 33.33K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
100K
Shares owned
N/A
Exercise price
14.45
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
123.07K
Shares owned
N/A
Exercise price
6.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
100K
Shares owned
N/A
Exercise price
48.46
Expiration
—
Exercise window
—
Total
Underlying
323.07K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Ordinary Shares | 14.45 | — | — | 100K | N/A |
| Stock Option (right to buy) Direct | Ordinary Shares | 6.00 | — | — | 123.07K | N/A |
| Stock Option (right to buy) Direct | Ordinary Shares | 48.46 | — | — | 100K | N/A |
| Total | 323.07K | 0.00 | ||||